baber/WOPTO huggingface dataset:
Patent DK-1689374-T3 (DK)
Inventor: CILURZO FRANCESCO
IPC: A23L33/15
Filed: 2004-10-27
Granted: 2008-10-13
Abstract: Rapidly dissolving self-supporting films for food or pharmaceutical use comprising: a) a filmogenic substance consisting of a maltodextrin; b) a plasticizer; c) an active principle for food or pharmaceutical use, characterized in that said films are free of hydrocolloids.
Patent DK-1687612-T3 (DK)
Inventor: BERNDTSSON INGEMAR
IPC: G01N/
Filed: 2004-11-24
Granted: 2012-01-16
Abstract: A method and a device for separating a small defined volume of a liquid sample from a relatively large undefined volume of the sample. In a surface of a first body (10) at least one cavity (12) having said small defined volume is provided. The relatively large volume of sample is applied onto the surface and into the cavity. A scraping edge (15) is moved relative to the surface and the cavity, thereby scraping a volume of the relatively large volume from the surface and leaving said small defined volume in the cavity.
Patent DK-1616878-T3 (DK)
Inventor: DESNOYERS LUC
IPC: C12P21/08
Filed: 2000-03-01
Granted: 2009-03-30
Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Patent DK-1704485-T3 (DK)
Inventor: LEPPANEN EVA-MARIA
IPC: H04W12/08
Filed: 2005-01-05
Granted: 2018-01-29
Abstract: A method of authorising in a communications system using authorising data. The authorising data being one of a data component, data group or data element to reference or to be referenced by other data to define the authorisation associated with the other data.
Patent DK-1730226-T3 (DK)
Inventor: PARKER DAVID ANDREW
IPC: C08K5/101
Filed: 2005-03-02
Granted: 2009-12-14
Abstract: Use of a compound of general formula (1) as a slip agent in a PET polymer, wherein: R and R1 represent hydrocarbon moieties, each hydrocarbon moiety comprising 6 to 24 carbon atoms and wherein R and/or R1 may be linear, branched chain, saturated or contain one or more double a bonds; X represents one of the moieties (a), wherein A represents a hydrocarbon moiety comprising 2 to 36 carbon atoms and may be linear, branched chain, saturated or contain one or more double bonds.
Patent DK-1828788-T3 (DK)
Inventor: SUN HONGQIAO
IPC: G01R23/00
Filed: 2005-12-09
Granted: 2012-05-21
Abstract: A method and apparatus are disclosed. The apparatus includes a store of at least one historical sensor measurement, a store of potential cut-off frequencies, and a filter. Each potential cut-off frequency is associated with a respective potential difference between a sensor measurement and the stored historical sensor measurement. The filter has a cut-off frequency dynamically selected from the stored potential cut-off frequencies on the basis of a difference between the stored historical sensor measurement and a current sensor measurement. The method includes determining a difference between a current sensor measurement and a historical sensor measurement; and dynamically selecting a cut-off frequency for a filter for the current sensor measurement from the difference.
Patent DK-2126350-T3 (DK)
Inventor: ANDERSEN CARSTEN BRUUN
IPC: F03D1/06
Filed: 2007-08-24
Granted: 2012-02-06
Abstract: A wind turbine includes a rotor having a hub from which a number of wind turbine blades extend, and a spinner mounted on the hub, wherein the spinner includes one or more apertures. The wind turbine is characterized in that it includes one or more aperture covers for entirely or partly covering one or more of the apertures in the spinner and in that the wind turbine further includes one or more aperture adjustment mechanisms for adjusting the effective size of one or more of the apertures, by displacement of one or more of the aperture covers. A method for establishing at least one aperture in the spinner on the hub of a wind turbine rotor and use of a wind turbine are also contemplated.
Patent DK-2046813-T3 (DK)
Inventor: KRATZ FELIX
IPC: A61K47/48
Filed: 2007-07-25
Granted: 2010-06-14
Abstract: The invention relates to methotrexate derivatives which contain a protein-binding group and can be enzymatically cleaved in the body such that the active substance or a low-molecular active substance derivative is released. Also disclosed is a method for producing methotrexate derivatives, the use thereof, and medicaments comprising methotrexate derivative.
Patent DK-2097835-T3 (DK)
Inventor: KALAFUT JOHN
IPC: G16H20/17
Filed: 2007-12-21
Granted: 2018-09-03
Abstract: A parameter generation system to determine parameters of a diagnostic injection protocol having at least one admixture phase in which an admixture inclusive of a pharmaceutical having a contrast enhancement agent and a diluent is injected into a patient, the parameter generation system comprising: 
     an algorithm for determining an initial ratio of the pharmaceutical to the diluent in the at least one admixture phase for the patient using information comprising a patient parameter available without performing a characterization of a cardiovascular system of the patient via a test bolus of the pharmaceutical, wherein the parameter of the patient is at least one of weight, body mass index, body surface area and cardiac output of the patient.
Patent DK-2131605-T3 (DK)
Inventor: NELSON MIKE
IPC: F16C11/06
Filed: 2009-05-11
Granted: 2011-01-03
Abstract: Headphones include a head harness and two ear pieces provided to respective ends of the head harness. Each ear piece is movably coupled to the head harness by a ball and socket arrangement structured to allow spherical articulation of each ear piece with respect to the head harness.
Patent DK-2154411-T3 (DK)
Inventor: EGGER KARL
IPC: F16L33/22
Filed: 2009-05-04
Granted: 2012-02-13
Abstract: The device connects a plastic pipe (1) to a connection fitting (2), where connecting ends (4) of the pipe have a front side chamfer (8) in an inner diameter region. The ends are axially retained between the fitting and a clamping piece (3). The pipe overlaps a sealing ring (5) that is retained in the fitting. The fitting in a connecting position of the pipe on a side of the ring opposite a front side (7) of the ends has a receiving groove (9) for a locking ring (10). Outer diameter of the locking ring is larger than inner diameter of the pipe, and smaller than outer diameter of the chamfer.
Patent DK-2418287-T3 (DK)
Inventor: VAN DONGEN JACOBUS JOHANNES MARIA
IPC: C12Q1/68
Filed: 2003-10-13
Granted: 2013-12-16
Abstract: The invention relates to PCR-based clonality studies for among others early diagnosis of lymphoproliferative disorders. Provided is a set of nucleic acid amplification primers comprising a forward primer, or a variant thereof, and a reverse primer, or a variant thereof, capable of amplifying a V²-J² TCRB rearrangement, and optionally a rearrangement selected from the group consisting of a VH-JH IGH rearrangement, a DH-JH IGH rearrangement, a VK-JK IGK rearrangement, a VK/intron-Kde IGK rearrangement, a V»-J» IGL rearrangement, a D²-J² TCRB rearrangement, a V³-J³ TCRG rearrangement, a V´-J´ TCRD rearrangement, a D´-D´ TCRD rearrangement, a D´-J´ TCRD rearrangement, a V´-D´ TCRD rearrangement, or a translocation selected from t(11;14)(BCL1-IGH) and t(14;18)(BCL2-ICrH). The primers can be used in PCR-based clonality studies for early diagnosis of lymphoproliferative disorders and detection of minimal residual disease (MRD). Also provided is a kit comprising at least one set of primers of the invention.
Patent DK-2488525-T3 (DK)
Inventor: DUFFY ERIN M
IPC: C07D487/04
Filed: 2010-10-15
Granted: 2018-08-06
Abstract: The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals.
Patent DK-2959021-T3 (DK)
Inventor: WIRTZ RALPH
IPC: C12Q1/68
Filed: 2014-08-19
Granted: 2018-09-10
Abstract: The present invention relates to an in vitro method of identifying a molecular subtype of a tumor in a cancer patient and to a method of stratifying a cancer patient for tumor treatment. The present invention further relates to kits that are useful for identifying a molecular subtype of a tumor in a cancer patient.
Patent DK-3072407-T3 (DK)
Inventor: DUBIEF FLAVIEN
IPC: A24F40/44
Filed: 2012-12-05
Granted: 2018-05-22
Abstract: There is provided an aerosol generating device comprising a storage portion (113, 501) for storing aerosol-forming substrate (115, 505). The device comprises: a vaporizer (119, 509) for heating the aerosol-forming substrate (115, 505), a capillary material (117, 507) for conveying the liquid aerosol-forming substrate (115, 505) from the storage portion (113, 501) towards the vaporizer (119, 509) by capillary action, and a porous material (201, 301, 405, 511) between the capillary material (117, 507) and the vaporizer (119, 509).
Patent DK-0435797-T3 (DK)
Inventor: ANDERMANN GUY
IPC: A61K9/00
Filed: 1990-12-10
Granted: 1995-01-16
Abstract: Therapeutic composition employed in ophthalmology. It combines calcium salts of glucoheptonic acid, biological organic acids and inorganic salts with gamma-aminobutyric acid to form a stable and effective solution, also containing sodium bicarbonate.
Patent DK-0462187-T3 (DK)
Inventor: MENEGUZZI GUERRINO
IPC: C12N15/863
Filed: 1990-03-06
Granted: 1993-10-18
Abstract: The invention concerns the use in a pharmaceutical composition for the prevention and treatment of papillomavirus-induced tumours, in particular the HPV-16 virus, of a recombinant poxvirus comprising an heterologous DNA sequence coding at least for the essential region of a non-structural papillomavirus protein as well as the regulation elements ensuring its expression in the higher cells. More particularly, it concerns the E5, E6, E7 proteins of the HPV-16 virus.
Patent DK-0483206-T3 (DK)
Inventor: LAWS ELIZABETH
IPC: F16L/
Filed: 1990-07-20
Granted: 1995-06-26
Abstract: PCT No. PCT/GB90/01124 Sec. 371 Date Mar. 6, 1992 Sec. 102(e) Date Mar. 6, 1992 PCT Filed Jul. 20, 1990 PCT Pub. No. WO91/01452 PCT Pub. Date Feb. 7, 1991.A flow conditioner comprising an apertured circular plate to be placed in a conduit in an orientation substantially perpendicular to the axis of the conduit. The apertures are circular and are arranged in a plurality of radially spaced circular arrays around a central aperture. The center of the central aperture and the centers of the circular arrays coincide with the center of the circular plate. The apertures in each circular array are equally spaced apart around the center of the plate, and all the apertures in any one circular array are of substantially the same diameter. The size and number of apertures are such that the impedance to flow presented by the plate increases with the radius on which a given array of apertures is arranged.
Patent DK-0485446-T3 (DK)
Inventor: FREAN ROBERT GEORGE
IPC: F17C13/08
Filed: 1990-08-02
Granted: 1996-10-21
Abstract: A restraining device for restraining a round object (13) from rolling. The restraining device (11) comprises a body (15) having a base (17) for location against a support surface, and an opening (18) capable of expansion and contraction for receiving and clampingly retaining the round object. The base (17) is adapted for and is capable of deformation for maintaining stable contact with the support surface upon expansion and contraction of the opening (18).
Patent DK-0490424-T3 (DK)
Inventor: JOHANSSON KJELL
IPC: C08L3/04
Filed: 1991-11-28
Granted: 1995-08-28
Abstract: Starch soln. is prepd. by mixing starch-contg. particles with cold water and subjecting to shear forces to break up any agglomerates and maintaining the temp. until the viscosity of the soln. has passed its maximum. The wetting and heating take place before the soln. becomes too viscous to handle. Pref. the temp. of the cold water is 0-35 deg.C.. All the starch particles are wetted within 5 mins.. The starch/water mixt. is subjected to shear forces in a device where it is continuously conducted through a housing contg. a rotator so that any agglomerates or lumps are broken up as the starch particles are wetted. The starch is highly cationised, has a degree of substitution at least 0.07 and the amount of starch is such that the dry content exceeds 2 wt.% during heating. The devices comprising combined mixers and heaters, and starch solns. free of unswelled grains are new.
Patent DK-0469856-T3 (DK)
Inventor: FREEMAN GARY T
IPC: H04N5/225
Filed: 1991-07-30
Granted: 1995-10-30
Abstract: An illuminated video probe in an aligning system for simultaneously viewing an object and a device acting on the object while illuminating the object and the device acting on the object directly along their respective viewing axes. A first optical beamsplitter and adjacent mirror surface act to simultaneously translate the object and device images to the video probe optical axis. A second optical beamsplitter, adjacent light source, and opaque surface act to illuminate the object along the viewing axis without causing light to project back toward the video probe. <IMAGE>
Patent DK-0468054-T3 (DK)
Inventor: OINUMA HITOSHI
IPC: C07C311/46
Filed: 1991-02-07
Granted: 1997-06-16
Abstract: A novel benzenesulfonamide derivative of formula (I) which has an action of inhibiting phospholipase A2 and therefore is effective in treating diseases for which this action is used to advantage.
Patent DK-0535150-T3 (DK)
Inventor: TEKAMP-OLSON PATRICIA
IPC: C07K14/52
Filed: 1991-06-24
Granted: 1995-05-15
Abstract: An attempt to identify the human counterpart of murine macrophage inflammatory protein 2 unexpectedly resulted in not one but two candidate sequences, designated hu-MIP-2 alpha  and hu-MIP- beta , respectively. By using the DNA sequences and recombinant systems provided by this invention, one can obtain hu-MIP-2 beta , one of the two human counterparts to mMIP-2, substantially free of other human protein. This invention also provides antibodies reactive with hu-MIP-2 DOLLAR (b) polypeptides as well as immunoassay methods for determining hu-MIP-2 beta  and nucleotide probes for detecting nucleotide sequences encoding hu-MIP-2 beta  in biological samples.
Patent DK-0496342-T3 (DK)
Inventor: YANAGI MIKIO
IPC: C07D319/14
Filed: 1992-01-21
Granted: 1997-03-03
Abstract: A novel hydrazine derivative represented by the following formula (I): <CHEM> where R<1> -R<1><2>,A,B and n are as defined in Claim 1, and a pesticidal composition containing the hydrazine derivative as the effecting ingredient. The hydrazine derivative show high pesticidal activity against harmful pests which are resistant to known pesticides such as organophosphorus pesticides, pyrethroids, etc., especially against Lepidopters harmful pests such as Plutella xylostella, Spodoptera litura, Cnaphalocrocis medinalis, Adoxophyes orana, etc., and is effective for controlling harmful pests in paddy field, upland field, orchard, forest or places to be kept environmentally hygienic.
Patent DK-0508330-T3 (DK)
Inventor: ZOBEL RUDOLF
IPC: B01D11/02
Filed: 1992-04-03
Granted: 1996-01-02
Abstract: A process for the preparation of extracts from Rhizoma petasitidis with a very low content of pyrrolizidine alkaloids by extraction of the plant material with compressed carbon dioxide at > 8 MPa and subsequent removal of the extract from the solvent by reducing the density is described, wherein the extract is treated, after the removal of the solvent, with one to ten times the amount of water, and the extract is dried after removal thereof from the aqueous phase. A high-quality petasites extract is prepared in this way and consists of up to 40% by weight of petasin and has a pyrrolizidine alkaloid content < 0.1 ppm.
Patent DK-0548532-T3 (DK)
Inventor: STRONG HENRY LEE
IPC: C07D213/78
Filed: 1992-11-16
Granted: 1997-05-12
Abstract: 5,6-Disubstd. 3-pyridylmethyl ammonium halide derivs. of formula (I) are new. In (I) Z = H or halogen; Z1 = H, halogen, CN or NO2; X = Cl, Br, I or R3SO3; R3 = 1-4C alkyl or Ph (opt. substd. with 1-3 gps. chosen from 1-4C alkoxy, 1-4C alkyl, NO2, CN or halogen); Y and Y1 = each OR4, NR4R5 or together form O, S or NR6; R4 and R5 = H, 1-4C alkyl (opt. substd.with 1-4C alkoxy or Ph itself opt. substd. with 1-3 gps. chosen from 1-4C alkyl, 1-4C alkoxy or halogen) or Ph (opt. substd. with 1-3 gps. chosen from 1-4C alkyl, 1-4C alkoxy or halogen); R6 = H or 1-4C alkyl; Q = RR1R2N(+) (a), (b), (c) etc. where R, R1 and R2 = each 1-4C alkyl or R and R1 together form a 5-6 membered ring in which RR1 forms (CH2)n, opt. interrupted by O, S or NR10, provided that R2 = 1-4C alkyl; n = 3-5; Z2 = O, S or NR10; R10 = 1-4C alkyl; R11 and R12 = each H, halogen, 1-4C alkyl or 1-4C alkoxy; or R11 and R12 together form a 5-6 membered satd. or unsatd. ring opt. interrupted by O, S or NO10 and opt. substd. with 1-3 gps. chosen from halogen, 1-4C alkyl or 1-4C alkoxy.
Patent DK-0545413-T3 (DK)
Inventor: BORCHERDING DAVID R
IPC: A61P21/04
Filed: 1992-12-03
Granted: 2000-10-09
Abstract: This invention relates to novel trans cyclopentanyl purine analogs of the formula (1) <CHEM>  wherein the substituent in the 3-position on the cyclopentanyl ring is in the Trans configuration relative to the bicyclic substituent, Y3, Y5 Y7, Y8 and Y9 are each independently nitrogen or a CH group,    R is a hydrogen, a C1-C7 alkyl acyl or aryl acyl,     Q is NH2, halogen or hydrogen,     Z is hydrogen, halogen, or NH2; or a pharmaceutically-acceptable salt thereof, and to their use as immunosuppressants.
Patent DK-0569369-T3 (DK)
Inventor: USZYCKA-HORAWA TERESA
IPC: C07J71/00
Filed: 1991-12-17
Granted: 1995-07-17
Abstract: By the method according to the invention condensation of 11 beta ,16 alpha ,17 alpha ,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 21-acetate with n-butyric aldehyde is carried out, in the known way, in the medium of hydrofluoric acid of concentration of 70-80 %. Theisolated crude condensation product is crystallized from ethanol and obtained 21-acetate of budesonide (22R) of at least 95 % content is hydrolyzed, and the product thus obtained is crystallized from ethyl acetate.
Patent DK-0583316-T3 (DK)
Inventor: RELIGA ZBIGNIEW
IPC: A61F2/24
Filed: 1992-05-08
Granted: 1997-04-14
Abstract: PCT No. PCT/EP92/01018 Sec. 371 Date Jan. 14, 1994 Sec. 102(e) Date Jan. 14, 1994 PCT Filed May 8, 1992 PCT Pub. No. WO92/19185 PCT Pub. Date Nov. 12, 1992.An elastic textile covering is applied over an annular support of a heart valve prosthesis by inserting the preferably collar shaped textile covering through the annular support, turning two projecting axial ends of the textile covering over the outer surface of the annular support and then joining the two axial ends to each other to form a seam that preferably extends entirely around an outer periphery of the annular support. This seam can be concealed by a collar, which also may be covered by the textile covering. An apparatus for applying the textile covering to the annular support includes two coaxial annular rings into which the annular support and textile covering are inserted. Each of the rings includes structure for attachment to a respective axial end of the textile covering.
Patent DK-0572823-T3 (DK)
Inventor: BEYER WOLFGANG
IPC: F16L5/10
Filed: 1993-05-11
Granted: 1997-05-26
Abstract: The invention relates to a wall lead-through for pipes, cables or lines. It comprises a hollow structural part which can be inserted in the wall through-passage and is sealed, in the lead-through region, with respect to the masonry work. Distributed over its length, the hollow structural part (1) has portions of different cross-section. Of these portions, the portion directed to the interior of the structure is a straight, elongate hollow part (11) which is adjoined, in the direction of the outer region of the masonry work, by a sealing portion (12). The sealing portion (12) is followed by a short, rigid portion (13) which is adjoined by a flexible portion (14) of any length. The flexible portion (14) terminates in an outer, cylindrical connection stub (15).
Patent DK-0590309-T3 (DK)
Inventor: TAKESHITA SUNAO
IPC: A61K36/062
Filed: 1993-08-25
Granted: 1999-09-20
Abstract: A bone-related protein named OSF-8 which is obtained from bone tissue of a mammal including mouse or human, and a process for its production. This protein is a novel naturally occurring mammal protein which belongs to a group of sulfatases. OSF-8 degrades the sulfate groups of the sugar chains of proteoglycan, which makes up the cartilage matrix, during the replacement of cartilage into bone tissue at the stage of osteogenesis. OSF-8 can be used as an agent for treating bone metabolic diseases, and its high organ specificity for bones enables its use as a diagnostic reagent for bone metabolic diseases. <IMAGE>
Patent DK-0589844-T3 (DK)
Inventor: BERNDT CLAUS
IPC: B65G1/04
Filed: 1993-09-21
Granted: 1996-09-16
Abstract: A high-performance warehouse comprises a plurality of horizontal storage levels (3) which are arranged one above the other and each of which is composed of channels (8', 8'') which are arranged parallel adjacent to one another and in which the individual stored piece goods (2) can be stored in rows one behind the other. Every channel (8) adjoins a lane which runs parallel to the latter and in which there is arranged a transport device (12) which can be moved along the said lane. By means of this transport device (12), the stored piece goods (2) can be removed from and brought into the channels (8). The stored piece goods (2) can be brought onto a transport means (26) which is arranged in every storage level (3), runs transversely with respect to the channels (8) and can take the stored piece goods (2) into a lift (11). The transport devices (12), transport means (26) and lift (11) can function independently of one another and autonomously so that only minimal waiting periods arise. <IMAGE>
Patent DK-0636112-T3 (DK)
Inventor: LI CHIEN-WEI
IPC: C04B35/80
Filed: 1993-04-08
Granted: 1997-09-22
Abstract: A silicon nitride sintered body has a composition consisting essentially of 85 to 94 % by weight  beta  silicon nitride, 6 to 15 % by weight grain boundary phase consisting essentially of (i) at least two rare earth elements, wherein yttrium is considered a rare earth, and, optionally, strontium which, calculated as SrO, is 0 to 2 percent by weight of the total body, and (ii) at least two of Si, N, O and C, and an additive consisting essentially of a metal carbon compound present in the amount of about 0.2 to 3.5 % by volume. The additive is substantially homogeneously dispersed within the sintered body. The sintered body has a microstructure wherein (i) the  beta silicon nitride grains are acicular and have an average grain width ranging from 0.5 to 1.5  mu m, (ii) at least 25 % of the grains have width greater than 0.7  mu m, and at least 10 % of the grains have width greater than 1  mu m, and (iii) no more than 5 % of grains have width greater than 3.5  mu m and apparent aspect ratio greater than 5, with the proviso that the average aspect ratio is at least 1.8 and a fracture origin, at least 90 % of which is comprised of large acicular  beta Si3N4 grains, the average size of which ranges from about 15 to 50  mu m. Such a ceramic has high strength, high toughness and long term durability, and is especially suited for industrial applications such as components for gas turbine and automotive engines.